Delivery Order SPE2DB20D9331-SPE2DB25FL1J8
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $13,697.84 by the Defense Logistics Agency on April 24, 2025, for the supply of Xolair 300 mg/2 ml auto-injector medications. The delivery order, which carries no set-aside designation, is scheduled for completion by May 15, 2025, with performance occurring at the company's Park Ridge facility. This award represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on September 9, 2025, for the supply of Xolair 300 mg/2 ml auto-injector vials. The contract has a ceiling value of $6,848.92 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. No set-aside designation was applied to this award, and performance will take place...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency on September 15, 2025, for Xolair 300 mg/2 ml auto-injector pharmaceutical products, with a ceiling value of $1,712.23. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,273.38 by the Defense Logistics Agency on August 15, 2025, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, carries no set-aside designation. The award represents a discrete fulfillment order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,122.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation. DMS Pharmaceutical Group is performing at its Park Ridge facility and delivering...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $10,273.38 by the Defense Logistics Agency on August 26, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. The contract carries no set-aside designation and is scheduled for completion by September 17, 2025, with performance taking place at the contractor's Park Ridge facility. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,273.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injector vials. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, represents a specific pharmaceutical procurement supporting military healthcare operations. The award carries no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,720.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL syringes. This firm fixed-price delivery order, issued on June 2, 2025, is scheduled for completion by June 24, 2025, with performance taking place at the vendor's Park Ridge facility. The award carries no set-aside designation, allowing DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,561.15 by the Defense Logistics Agency (DLA) on September 15, 2025. The delivery order, which has an ultimate completion date of October 6, 2025, is for the supply of Xolair 300 mg/2 ml auto-injector syringes to support Department of Defense healthcare operations. This award carries no set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,162.88 by the Defense Logistics Agency on September 23, 2025, for the supply of Xolair 300 mg/2 ml syringes. The contract, which carries a firm fixed-price structure with no set-aside designation, is scheduled for ultimate completion by October 15, 2025, and will be performed at the company's Park Ridge facility. This delivery order...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1J8Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on June 4, 2025, for the supply of Xolair 300 mg/2 mL auto-injector vials. This firm fixed-price delivery order, valued at $1,712.23, is set to be completed by June 26, 2025, with performance occurring at the vendor's facility in Park Ridge. The award does not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal pharmaceutical procurement marketplace based on its capabilities as an established small business supplier. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. The SPE2DB program enables the DLA to issue firm fixed-price orders for medications, biologics, medical consumables, and specialty pharmaceutical items to support military health operations globally. DMS Pharmaceutical Group's established position as a primary pharmaceutical distributor to federal agencies positions the company as a critical supply chain partner for the Defense Logistics Agency's pharmaceutical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/4/25 |